Study identifier:4522IL/0065
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A 6 week Open Label, Dose Comparison Study to Evaluate the Safety and Efficacy of Rosuvastatin versus Atorvastatin, Pravastatin, and Simvastatin in subjects with Hypercholesterolemia.
Hypercholesterolemia
Phase 3
No
Rosuvastatin, Atorvastatin, Pravastatin, Simvastatin
All
5625
Interventional
18 Years +
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Verified 01 Dec 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
Experimental: 1 Rosuvastatin | - |
Active Comparator: 2 Atorvastatin | - |
Active Comparator: 3 Pravastatin | - |
Active Comparator: 4 Simvastatin | - |